- Home
- KURA vs CCBG Comparison
KURA vs CCBG Comparison
Compare KURA & CCBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KURA | CCBG |
|---|---|---|
| Founded | 2014 | 1895 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 874.1M |
| IPO Year | 2015 | 1994 |
Fundamental Metrics
Financial Performance| Metric | KURA | CCBG |
|---|---|---|
| Price | $10.91 | $49.05 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 1 |
| Target Price | $25.56 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 1.8M | 53.1K |
| Earning Date | 05-12-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 2.34% |
| EPS Growth | N/A | ★ 15.38 |
| EPS | N/A | ★ 0.92 |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $28.28 | $6.25 |
| Revenue Next Year | $106.37 | $3.17 |
| P/E Ratio | ★ N/A | $52.99 |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $7.36 | $38.27 |
| 52 Week High | $13.90 | $53.60 |
Technical Indicators
Market Signals| Indicator | KURA | CCBG |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 35.31 |
| Support Level | $8.45 | $47.63 |
| Resistance Level | $11.40 | $52.38 |
| Average True Range (ATR) | 0.48 | 0.92 |
| MACD | -0.18 | -0.19 |
| Stochastic Oscillator | 6.75 | 11.18 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services, among others, through its banking offices in Florida, Georgia, and Alabama.